Tag: Cancer: Lymphoma
ASH: Axicabtagene Ciloleucel Slows Large B-Cell Lymphoma
Event-free survival prolonged with axi-cel versus standard care as second-line therapy for refractory, relapsed disease
Stem Cell Transplant Reviewed for Peripheral T-Cell Lymphoma
Three- and five-year overall survival similar with allogeneic or autologous HSCT, but transplant-related mortality higher with allogeneic HSCT
Novel Index IDs Prognosis in Adults With Burkitt Lymphoma
Validated international prognostic index stratifies patients according to low, intermediate, high risk
Breyanzi Approved for Certain Types of Large B-Cell Lymphoma
The CAR T cell therapy OK'd for patients who have not responded to or have relapsed after receiving two or more other systemic treatments
ASH: CAR T-Cell Therapy Promising for Relapsed/Refractory iNHL
Phase 2 study reveals high objective response rate for CAR T-cell therapy in patients with follicular lymphoma, marginal zone lymphoma
Rates of VTE, Major Bleeding High in Primary CNS Lymphoma
Pulmonary embolism and major bleeding linked to increased mortality risk
Relationship Explored Between Physical Activity and Lymphoma
Dose-response analysis showed protective effect with 1 percent risk reduction per three MET hours/week
Most Women Unaware of Breast Implant-Related Lymphoma
Even among women with breast implants, just over half have heard of BIA-ALCL
Incidence of VTE, Major Bleeding High in Primary CNS Lymphoma
VTE risk up with chemotherapy, radiation therapy; major bleeding risk up with PE, proximal DVT
